Deutsche Bank Maintains a 'Hold' on Dollar Tree (DLTR); Q2 Preview: Risk vs. Reward
Get Alerts DLTR Hot Sheet
Price: $129.39 -0.11%
Rating Summary:
17 Buy, 22 Hold, 6 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
17 Buy, 22 Hold, 6 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Deutsche Bank maintains a 'Hold' on Dollar Tree (NASDAQ: DLTR) price target of $54.00.
Analyst, Charles Grom, said, "Dollar Tree will report 2Q12 earnings on 8/16. We’re modeling 2Q EPS of $0.47 (+21% YOY), in-line with Consensus and at the high-end of guidance. Our forecast is based on a +5.0% comp. While DLTR shares are up +25.0% YTD vs. +11.4% S&P 500, we see limited near-term upside given: (1) valuation at ~17x our FY13 EPS (a premium to competitors), and (2) less EPS upside given macro/inflation uncertainty. Provided the less enticing risk/reward, we believe DLTR shares are fairly valued today."
For an analyst ratings summary and ratings history on Dollar Tree click here. For more ratings news on Dollar Tree click here.
Shares of Dollar Tree closed at $50.72 yesterday.
Analyst, Charles Grom, said, "Dollar Tree will report 2Q12 earnings on 8/16. We’re modeling 2Q EPS of $0.47 (+21% YOY), in-line with Consensus and at the high-end of guidance. Our forecast is based on a +5.0% comp. While DLTR shares are up +25.0% YTD vs. +11.4% S&P 500, we see limited near-term upside given: (1) valuation at ~17x our FY13 EPS (a premium to competitors), and (2) less EPS upside given macro/inflation uncertainty. Provided the less enticing risk/reward, we believe DLTR shares are fairly valued today."
For an analyst ratings summary and ratings history on Dollar Tree click here. For more ratings news on Dollar Tree click here.
Shares of Dollar Tree closed at $50.72 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
- Pro Diversity Network (IPDN) Reports Q2 Loss of $0.15
- Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS ViewRelated Entities
Deutsche Bank, Standard & Poor's, EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share